OnKure Therapeutics Ownership | Who Owns OnKure Therapeutics?

OnKure Therapeutics Ownership Summary

OnKure Therapeutics is owned by 25.69% institutional investors, 10.48% insiders, and 63.84% retail investors. Ra capital management is the largest institutional shareholder, holding 29.58% of OKUR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.24% of its assets in OnKure Therapeutics shares.

OKUR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	OnKure Therapeutics	25.69%	10.48%	63.84%
Sector	Healthcare Stocks	35.52%	11.86%	52.62%
Industry	Biotech Stocks	35.67%	11.81%	52.52%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	4.00M	29.58%	$16.55M
Acorn capital advisors	2.84M	21.01%	$11.76M
Stepstone group lp	2.66M	19.68%	$11.01M
Prosight management, lp	2.15M	15.94%	$8.92M
Bvf inc/il	1.98M	14.64%	$8.19M
Vivo capital	1.93M	14.26%	$7.98M
Vestal point capital, lp	1.84M	13.61%	$7.62M
Foresite capital management vi	1.45M	10.70%	$5.99M
Adage capital partners gp	1.20M	8.91%	$4.99M
Sio capital management	1.08M	7.98%	$4.47M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Stepstone group lp	2.66M	5.31%	$11.01M
Acorn capital advisors	2.84M	3.34%	$11.76M
Prosight management, lp	2.15M	1.46%	$8.92M
Foresite capital management vi	1.45M	1.30%	$5.99M
Rosalind advisors	443.76K	0.74%	$1.84M
Vivo capital	1.93M	0.67%	$7.98M
Sio capital management	1.08M	0.64%	$4.47M
Rangeley capital	95.00K	0.38%	$393.30K
Bvf inc/il	1.98M	0.26%	$8.19M
Stonepine capital management	132.58K	0.22%	$548.87K

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	4.00M	0.18%	4.00M
Stepstone group lp	2.66M	5.31%	2.17M
Bvf inc/il	1.98M	0.26%	1.98M
Vivo capital	1.93M	0.67%	1.93M
Foresite capital management vi	1.45M	1.30%	1.45M

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-1.84M
Perceptive advisors	-	-	-1.00M
Samsara biocapital	-	-	-824.15K
Shay capital	132.22K	0.05%	-648.64K
Highbridge capital management	-	-	-542.36K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	4.00M	0.18%	4.00M	$16.55M
Bvf inc/il	1.98M	0.26%	1.98M	$8.19M
Vivo capital	1.93M	0.67%	1.93M	$7.98M
Foresite capital management vi	1.45M	1.30%	1.45M	$5.99M
Adage capital partners gp	1.20M	0.01%	1.20M	$4.99M

Sold Out

Holder	Change
Northwestern mutual wealth management	-2.00
Mai capital management	-6.00
Group one trading	-56.00
Gf fund management	-271.00
Fmr	-400.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	22	-47.62%	3,471,972	-68.59%	25	0.38%	11	-35.29%	6	-57.14%
Dec 31, 2025	26	-38.10%	6,391,960	-37.45%	47	0.83%	12	-29.41%	10	-16.67%
Sep 30, 2025	42	-8.70%	10,219,608	5.81%	75	1.48%	17	-19.05%	12	-7.69%
Jun 30, 2025	48	4.35%	10,776,588	-9.78%	79	1.01%	23	-50.00%	13	-
Mar 31, 2025	2	-	710,559	-	5	-	2	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	510.16K	1.24%	-
Vanguard Institutional Extnd Mkt Idx Tr	72.32K	0.18%	-
Fidelity Extended Market Index	42.10K	0.10%	4.90K
iShares Micro-Cap ETF	28.01K	0.07%	-
Dimensional US Small Cap ETF	21.15K	0.05%	-
Extended Equity Market Fund B	20.01K	0.05%	-
Blackrock Extended Mkt Fund CF	20.01K	0.05%	-
Extended Equity Market Fund E	20.01K	0.05%	-
Fidelity Total Market Index	17.18K	0.04%	-
BlackRock Extended Equity Market Fund K	17.04K	0.04%	-125.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 23, 2026	Saccomano Nicholas A	President and CEO	Sell	$357.46
Mar 23, 2026	Leverone Jason A.	Chief Financial Officer	Sell	$1.25K
Dec 22, 2025	Saccomano Nicholas A	President and CEO	Sell	$258.19
Dec 22, 2025	Leverone Jason A.	Chief Financial Officer	Sell	$896.25
Sep 22, 2025	Saccomano Nicholas A	President and CEO	Sell	$230.87

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	2
2025 Q4	-	2
2025 Q3	-	2
2025 Q2	2	8

OKUR Ownership FAQ

Who Owns OnKure Therapeutics?

OnKure Therapeutics shareholders are primarily institutional investors at 25.69%, followed by 10.48% insiders and 63.83% retail investors. The average institutional ownership in OnKure Therapeutics's industry, Biotech Stocks , is 35.67%, which OnKure Therapeutics falls below.

Who owns the most shares of OnKure Therapeutics?

OnKure Therapeutics’s largest shareholders are Ra capital management (4M shares, 29.58%), Acorn capital advisors (2.84M shares, 21.01%), and Stepstone group lp (2.66M shares, 19.68%). Together, they hold 70.28% of OnKure Therapeutics’s total shares outstanding.

Does Blackrock own OnKure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of OnKure Therapeutics.

Who is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested?

Stepstone group lp is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.31% of its assets in 2.66M OnKure Therapeutics shares, valued at 11.01M$.

Who is the top mutual fund holder of OnKure Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of OnKure Therapeutics shares, with 1.24% of its total shares outstanding invested in 510.16K OnKure Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools